VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether reduction of homocysteine levels with
high-dose folate (folic acid), B6, and B12 supplementation will slow the rate of cognitive
decline in persons with Alzheimer's disease.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute on Aging (NIA)
Collaborator:
Alzheimer's Disease Cooperative Study (ADCS)
Treatments:
Hydroxocobalamin Pyridoxal Pyridoxine Vitamin B 12 Vitamin B 6 Vitamin B Complex Vitamins